2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Endometrial Hyperplasia Without Atypia: new trials by email Literature Review of Endometrial Hyperplasia Without Atypia trials Research Report on Endometrial Hyperplasia Without Atypia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia Medroxyprogesterone Acetate, Dydrogesterone 10 MG - Endometrial Hyperplasia Without Atypia | Phase 3 | Completed | Xiaojun Chen | 471 | 2019-02-26 | 2023-02-17 |
| Longitudinal Follow-up in Women With Endometrial Hyperplasia Without Atypia Metformin - Female, Endometrial Hyperplasia Without Atypia | Phase 3 | Completed | Chang Gung Memorial Hospital | 1000 | 2018-08-01 | 2026-10-08 |
Dydrogesterone (1) · Medroxyprogesterone Acetate (1) · Metformin (1)
Chang Gung Memorial Hospital (1) · Xiaojun Chen (1)
China (1) · Taiwan (1)